<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-11-02" modified="2020-10-07" version="201">
<accession>Q13950</accession>
<accession>O14614</accession>
<accession>O14615</accession>
<accession>O95181</accession>
<name>RUNX2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Runt-related transcription factor 2</fullName>
</recommendedName>
<alternativeName>
<fullName>Acute myeloid leukemia 3 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Core-binding factor subunit alpha-1</fullName>
<shortName>CBF-alpha-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Oncogene AML-3</fullName>
</alternativeName>
<alternativeName>
<fullName>Osteoblast-specific transcription factor 2</fullName>
<shortName>OSF-2</shortName>
</alternativeName>
<alternativeName>
<fullName>Polyomavirus enhancer-binding protein 2 alpha A subunit</fullName>
<shortName>PEA2-alpha A</shortName>
<shortName>PEBP2-alpha A</shortName>
</alternativeName>
<alternativeName>
<fullName>SL3-3 enhancer factor 1 alpha A subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>SL3/AKV core-binding factor alpha A subunit</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RUNX2</name>
<name type="synonym">AML3</name>
<name type="synonym">CBFA1</name>
<name type="synonym">OSF2</name>
<name type="synonym">PEBP2A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Cell" volume="89" first="773" last="779">
<title>Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.</title>
<authorList>
<person name="Mundlos S."/>
<person name="Otto F."/>
<person name="Mundlos C."/>
<person name="Mulliken J.B."/>
<person name="Aylsworth A.S."/>
<person name="Albright S."/>
<person name="Lindhout D."/>
<person name="Cole W.G."/>
<person name="Henn W."/>
<person name="Knoll J.H.M."/>
<person name="Owen M.J."/>
<person name="Mertelsmann R."/>
<person name="Zabel B.U."/>
<person name="Olsen B.R."/>
</authorList>
<dbReference type="PubMed" id="9182765"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80260-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANT CLCD ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-84 INS</scope>
<scope>VARIANT 78-ALA--ALA-83 DEL</scope>
<scope>INVOLVEMENT IN CLCD</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Mamm. Genome" volume="9" first="54" last="57">
<title>Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function.</title>
<authorList>
<person name="Geoffroy V."/>
<person name="Corral D.A."/>
<person name="Zhou L."/>
<person name="Lee B."/>
<person name="Karsenty G."/>
</authorList>
<dbReference type="PubMed" id="9434946"/>
<dbReference type="DOI" id="10.1007/s003359900679"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORMS 1 AND 3)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="Gene" volume="214" first="187" last="197">
<title>Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor.</title>
<authorList>
<person name="Xiao Z.S."/>
<person name="Thomas R."/>
<person name="Hinson T.K."/>
<person name="Quarles L.D."/>
</authorList>
<dbReference type="PubMed" id="9651525"/>
<dbReference type="DOI" id="10.1016/s0378-1119(98)00227-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-19 (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="367" last="371">
<title>The cDNA cloning of the transcripts of human PEBP2alphaA/CBFA1 mapped to 6p12.3-p21.1, the locus for cleidocranial dysplasia.</title>
<authorList>
<person name="Zhang Y.-W."/>
<person name="Bae S.-C."/>
<person name="Takahashi E."/>
<person name="Ito Y."/>
</authorList>
<dbReference type="PubMed" id="9233771"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201352"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 60-521 (ISOFORM 3)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="37280" last="37291">
<title>Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex.</title>
<authorList>
<person name="Willis D.M."/>
<person name="Loewy A.P."/>
<person name="Charlton-Kachigian N."/>
<person name="Shao J.-S."/>
<person name="Ornitz D.M."/>
<person name="Towler D.A."/>
</authorList>
<dbReference type="PubMed" id="12145306"/>
<dbReference type="DOI" id="10.1074/jbc.m206482200"/>
</citation>
<scope>INTERACTION WITH XRCC5 AND XRCC6</scope>
<source>
<tissue>Osteoblast</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="2729" last="2740">
<title>MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2.</title>
<authorList>
<person name="Pelletier N."/>
<person name="Champagne N."/>
<person name="Stifani S."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="11965546"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205367"/>
</citation>
<scope>INTERACTION WITH KAT6A AND KAT6B</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="7118" last="7128">
<title>Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.</title>
<authorList>
<person name="Qiao M."/>
<person name="Shapiro P."/>
<person name="Fosbrink M."/>
<person name="Rus H."/>
<person name="Kumar R."/>
<person name="Passaniti A."/>
</authorList>
<dbReference type="PubMed" id="16407259"/>
<dbReference type="DOI" id="10.1074/jbc.m508162200"/>
</citation>
<scope>INTERACTION WITH CCNB1</scope>
<scope>PHOSPHORYLATION AT SER-451 BY CDK1</scope>
<scope>MUTAGENESIS OF SER-451</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Nature" volume="446" first="685" last="689">
<title>Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.</title>
<authorList>
<person name="Ono M."/>
<person name="Yaguchi H."/>
<person name="Ohkura N."/>
<person name="Kitabayashi I."/>
<person name="Nagamura Y."/>
<person name="Nomura T."/>
<person name="Miyachi Y."/>
<person name="Tsukada T."/>
<person name="Sakaguchi S."/>
</authorList>
<dbReference type="PubMed" id="17377532"/>
<dbReference type="DOI" id="10.1038/nature05673"/>
</citation>
<scope>INTERACTION WITH FOXP3</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340 (ISOFORM 3)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="92" first="252" last="258">
<title>Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly is caused by a duplication in RUNX2.</title>
<authorList>
<consortium name="FORGE Canada Consortium"/>
<person name="Moffatt P."/>
<person name="Ben Amor M."/>
<person name="Glorieux F.H."/>
<person name="Roschger P."/>
<person name="Klaushofer K."/>
<person name="Schwartzentruber J.A."/>
<person name="Paterson A.D."/>
<person name="Hu P."/>
<person name="Marshall C."/>
<person name="Fahiminiya S."/>
<person name="Majewski J."/>
<person name="Beaulieu C.L."/>
<person name="Boycott K.M."/>
<person name="Rauch F."/>
</authorList>
<dbReference type="PubMed" id="23290074"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2012.12.001"/>
</citation>
<scope>INVOLVEMENT IN MDMHB</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-238</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="Nat. Genet." volume="16" first="307" last="310">
<title>Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia.</title>
<authorList>
<person name="Lee B."/>
<person name="Thirunavukkarasu K."/>
<person name="Zhou L."/>
<person name="Pastore L."/>
<person name="Baldini A."/>
<person name="Hecht J."/>
<person name="Geoffroy V."/>
<person name="Ducy P."/>
<person name="Karsenty G."/>
</authorList>
<dbReference type="PubMed" id="9207800"/>
<dbReference type="DOI" id="10.1038/ng0797-307"/>
</citation>
<scope>VARIANTS CLCD ARG-175 AND ASN-191</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="65" first="1268" last="1278">
<title>Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia.</title>
<authorList>
<person name="Quack I."/>
<person name="Vonderstrass B."/>
<person name="Stock M."/>
<person name="Aylsworth A.S."/>
<person name="Becker A."/>
<person name="Brueton L."/>
<person name="Lee P.J."/>
<person name="Majewski F."/>
<person name="Mulliken J.B."/>
<person name="Suri M."/>
<person name="Zenker M."/>
<person name="Mundlos S."/>
<person name="Otto F."/>
</authorList>
<dbReference type="PubMed" id="10521292"/>
<dbReference type="DOI" id="10.1086/302622"/>
</citation>
<scope>VARIANTS CLCD ARG-113; ARG-118; CYS-121; ARG-123; ARG-205; GLN-225 AND TRP-225</scope>
<scope>VARIANT SER-511</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="2311" last="2316">
<title>CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia.</title>
<authorList>
<person name="Zhou G."/>
<person name="Chen Y."/>
<person name="Zhou L."/>
<person name="Thirunavukkarasu K."/>
<person name="Hecht J."/>
<person name="Chitayat D."/>
<person name="Gelb B.D."/>
<person name="Pirinen S."/>
<person name="Berry S.A."/>
<person name="Greenberg C.R."/>
<person name="Karsenty G."/>
<person name="Lee B."/>
</authorList>
<dbReference type="PubMed" id="10545612"/>
<dbReference type="DOI" id="10.1093/hmg/8.12.2311"/>
</citation>
<scope>VARIANTS CLCD ASN-133 DEL; GLN-169; ARG-175; GLN-190; ASN-191; CYS-193; PHE-199; ALA-200; ARG-209 AND GLN-225</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="Gene" volume="244" first="21" last="28">
<title>PEBP2alphaA/CBFA1 mutations in Japanese cleidocranial dysplasia patients.</title>
<authorList>
<person name="Zhang Y.-W."/>
<person name="Yasui N."/>
<person name="Kakazu N."/>
<person name="Abe T."/>
<person name="Takada K."/>
<person name="Imai S."/>
<person name="Sato M."/>
<person name="Nomura S."/>
<person name="Ochi T."/>
<person name="Okuzumi S."/>
<person name="Nogami H."/>
<person name="Nagai T."/>
<person name="Ohashi H."/>
<person name="Ito Y."/>
</authorList>
<dbReference type="PubMed" id="10689183"/>
<dbReference type="DOI" id="10.1016/s0378-1119(99)00558-2"/>
</citation>
<scope>VARIANT CLCD SER-197</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="16" first="277" last="277">
<title>A novel CBFA1 mutation (R190W) in an Italian family with cleidocranial dysplasia.</title>
<authorList>
<person name="Giannotti A."/>
<person name="Tessa A."/>
<person name="Patrono C."/>
<person name="De Florio L."/>
<person name="Velardo M."/>
<person name="Dionisi-Vici C."/>
<person name="Bertini E."/>
<person name="Santorelli F.M."/>
</authorList>
<dbReference type="PubMed" id="10980549"/>
<dbReference type="DOI" id="10.1002/1098-1004(200009)16:3&lt;277::aid-humu25&gt;3.0.co;2-v"/>
</citation>
<scope>VARIANT CLCD TRP-190</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="71" first="724" last="738">
<title>Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations.</title>
<authorList>
<person name="Yoshida T."/>
<person name="Kanegane H."/>
<person name="Osato M."/>
<person name="Yanagida M."/>
<person name="Miyawaki T."/>
<person name="Ito Y."/>
<person name="Shigesada K."/>
</authorList>
<dbReference type="PubMed" id="12196916"/>
<dbReference type="DOI" id="10.1086/342717"/>
</citation>
<scope>VARIANTS CLCD TRP-190; SER-197; ASN-218; ILE-220; TRP-225 AND GLN-225</scope>
<scope>CHARACTERIZATION OF VARIANTS CLCD TRP-190; SER-197; ASN-218; ILE-220; TRP-225 AND GLN-225</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Clin. Genet." volume="61" first="349" last="353">
<title>New mutations in the CBFA1 gene in two Mexican patients with cleidocranial dysplasia.</title>
<authorList>
<person name="Machuca-Tzili L."/>
<person name="Monroy-Jaramillo N."/>
<person name="Gonzalez-del Angel A."/>
<person name="Kofman-Alfaro S."/>
</authorList>
<dbReference type="PubMed" id="12081718"/>
<dbReference type="DOI" id="10.1034/j.1399-0004.2002.610505.x"/>
</citation>
<scope>VARIANT CLCD LEU-53</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Eur. J. Pediatr." volume="161" first="619" last="622">
<title>Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia.</title>
<authorList>
<person name="Morava E."/>
<person name="Karteszi J."/>
<person name="Weisenbach J."/>
<person name="Caliebe A."/>
<person name="Mundlos S."/>
<person name="Mehes K."/>
</authorList>
<dbReference type="PubMed" id="12424590"/>
<dbReference type="DOI" id="10.1007/s00431-002-0977-x"/>
</citation>
<scope>VARIANT CLCD PRO-169</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="19" first="209" last="216">
<title>Mutations in the RUNX2 gene in patients with cleidocranial dysplasia.</title>
<authorList>
<person name="Otto F."/>
<person name="Kanegane H."/>
<person name="Mundlos S."/>
</authorList>
<dbReference type="PubMed" id="11857736"/>
<dbReference type="DOI" id="10.1002/humu.10043"/>
</citation>
<scope>VARIANTS CLCD GLY-156; PRO-169; TRP-190; LYS-201; TRP-225; GLN-225 AND VAL-362</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="J. Cell. Physiol." volume="207" first="114" last="122">
<title>Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype.</title>
<authorList>
<person name="Kim H.-J."/>
<person name="Nam S.-H."/>
<person name="Kim H.-J."/>
<person name="Park H.-S."/>
<person name="Ryoo H.-M."/>
<person name="Kim S.-Y."/>
<person name="Cho T.-J."/>
<person name="Kim S.-G."/>
<person name="Bae S.-C."/>
<person name="Kim I.-S."/>
<person name="Stein J.L."/>
<person name="van Wijnen A.J."/>
<person name="Stein G.S."/>
<person name="Lian J.B."/>
<person name="Choi J.-Y."/>
</authorList>
<dbReference type="PubMed" id="16270353"/>
<dbReference type="DOI" id="10.1002/jcp.20552"/>
</citation>
<scope>VARIANTS CLCD GLY-131 AND GLN-225</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Genet. Mol. Res." volume="9" first="41" last="47">
<title>A novel RUNX2 mutation (T420I) in Chinese patients with cleidocranial dysplasia.</title>
<authorList>
<person name="Wang G.X."/>
<person name="Sun R.P."/>
<person name="Song F.L."/>
</authorList>
<dbReference type="PubMed" id="20082269"/>
<dbReference type="DOI" id="10.4238/vol9-1gmr685"/>
</citation>
<scope>VARIANT CLCD ILE-420</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="E1587" last="E1593">
<title>Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia.</title>
<authorList>
<person name="Ott C.E."/>
<person name="Leschik G."/>
<person name="Trotier F."/>
<person name="Brueton L."/>
<person name="Brunner H.G."/>
<person name="Brussel W."/>
<person name="Guillen-Navarro E."/>
<person name="Haase C."/>
<person name="Kohlhase J."/>
<person name="Kotzot D."/>
<person name="Lane A."/>
<person name="Lee-Kirsch M.A."/>
<person name="Morlot S."/>
<person name="Simon M.E.H."/>
<person name="Steichen-Gersdorf E."/>
<person name="Tegay D.H."/>
<person name="Peters H."/>
<person name="Mundlos S."/>
<person name="Klopocki E."/>
</authorList>
<dbReference type="PubMed" id="20648631"/>
<dbReference type="DOI" id="10.1002/humu.21298"/>
</citation>
<scope>VARIANTS CLCD ASN-118; SER-131; CYS-131; PRO-136; ASP-156; VAL-175; LYS-175; SER-187; GLN-193; ILE-200; HIS-209; PRO-211; GLN-218; GLU-218; LEU-225; GLY-228; ARG-233; ASN-287 AND ASN-420</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Oral Dis." volume="16" first="55" last="60">
<title>RUNX2 mutations in cleidocranial dysplasia patients.</title>
<authorList>
<person name="Ryoo H.M."/>
<person name="Kang H.Y."/>
<person name="Lee S.K."/>
<person name="Lee K.E."/>
<person name="Kim J.W."/>
</authorList>
<dbReference type="PubMed" id="19744171"/>
<dbReference type="DOI" id="10.1111/j.1601-0825.2009.01623.x"/>
</citation>
<scope>VARIANT CLCD TRP-225</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Oral Health Dent. Manag." volume="13" first="548" last="551">
<title>A case of cleidocranial dysplasia with peculiar dental features: pathogenetic role of the RUNX2 mutation and long term follow-up.</title>
<authorList>
<person name="Callea M."/>
<person name="Bellacchio E."/>
<person name="Di Stazio M."/>
<person name="Fattori F."/>
<person name="Bertini E."/>
<person name="Yavuz I."/>
<person name="Clarich G."/>
<person name="Gunay A."/>
</authorList>
<dbReference type="PubMed" id="24984680"/>
</citation>
<scope>VARIANT CLCD CYS-131</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2018" name="J. Cell. Biochem." volume="119" first="1152" last="1162">
<title>A novel RUNX2 mutation in exon 8, G462X, in a patient with Cleidocranial Dysplasia.</title>
<authorList>
<person name="Jung Y.J."/>
<person name="Bae H.S."/>
<person name="Ryoo H.M."/>
<person name="Baek S.H."/>
</authorList>
<dbReference type="PubMed" id="28703881"/>
<dbReference type="DOI" id="10.1002/jcb.26283"/>
</citation>
<scope>VARIANTS CLCD ARG-175; GLN-190; GLN-225 AND 462-GLY--TYR-521 DEL</scope>
<scope>CHARACTERIZATION OF VARIANT CLCD 462-GLY--TYR-521 DEL</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="Mutagenesis" volume="32" first="437" last="443">
<title>Functional analysis of novel RUNX2 mutations in cleidocranial dysplasia.</title>
<authorList>
<person name="Zeng L."/>
<person name="Wei J."/>
<person name="Han D."/>
<person name="Liu H."/>
<person name="Liu Y."/>
<person name="Zhao N."/>
<person name="Sun S."/>
<person name="Wang Y."/>
<person name="Feng H."/>
</authorList>
<dbReference type="PubMed" id="28505335"/>
<dbReference type="DOI" id="10.1093/mutage/gex012"/>
</citation>
<scope>VARIANTS CLCD GLY-193 AND 400-TYR--TYR-521 DEL</scope>
<scope>CHARACTERIZATION OF VARIANTS CLCD GLY-193 AND 400-TYR--TYR-521 DEL</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2017" name="PLoS ONE" volume="12" first="E0181653" last="E0181653">
<title>Analysis of novel RUNX2 mutations in Chinese patients with cleidocranial dysplasia.</title>
<authorList>
<person name="Zhang X."/>
<person name="Liu Y."/>
<person name="Wang X."/>
<person name="Sun X."/>
<person name="Zhang C."/>
<person name="Zheng S."/>
</authorList>
<dbReference type="PubMed" id="28738062"/>
<dbReference type="DOI" id="10.1371/journal.pone.0181653"/>
</citation>
<scope>VARIANTS CLCD 67-GLN--TYR-521 DEL; ARG-113; THR-186 AND TRP-225</scope>
<scope>CHARACTERIZATION OF VARIANTS CLCD 67-GLN--TYR-521 DEL; ARG-113; THR-186 AND TRP-225</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="3 12 25 26 27">Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis (PubMed:28505335, PubMed:28738062, PubMed:28703881). Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I) collagen, LCK, IL-3 and GM-CSF promoters. In osteoblasts, supports transcription activation: synergizes with SPEN/MINT to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Inhibits KAT6B-dependent transcriptional activation.</text>
</comment>
<comment type="subunit">
<text evidence="4 5 12 14 18 19">Heterodimer of an alpha and a beta subunit. The alpha subunit binds DNA as a monomer and through the Runt domain. DNA-binding is increased by heterodimerization. Interacts with XRCC6 (Ku70) and XRCC5 (Ku80). Interacts with HIVEP3. Interacts with IFI204. Interaction with SATB2; the interaction results in enhanced DNA binding and transactivation by these transcription factors. Binds to HIPK3. Interacts (isoform 3) with DDX5. Interacts with FOXO1 (via a C-terminal region); the interaction inhibits RUNX2 transcriptional activity towards BGLAP. This interaction is prevented on insulin or IGF1 stimulation as FOXO1 is exported from the nucleus (By similarity). Interacts with CCNB1, KAT6A and KAT6B. Interacts with FOXP3. Interacts with TMEM119 (By similarity). Interacts with OLFM2 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-976402">
<id>Q13950</id>
</interactant>
<interactant intactId="EBI-714158">
<id>Q13526</id>
<label>PIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-976402">
<id>Q13950</id>
</interactant>
<interactant intactId="EBI-1551512">
<id>O15297</id>
<label>PPM1D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-976402">
<id>Q13950</id>
</interactant>
<interactant intactId="EBI-976374">
<id>O43541</id>
<label>SMAD6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-976402">
<id>Q13950</id>
</interactant>
<interactant intactId="EBI-389606">
<id>O15350</id>
<label>TP73</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-976402">
<id>Q13950</id>
</interactant>
<interactant intactId="EBI-396235">
<id>P17480</id>
<label>UBTF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="25 27">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q13950-1</id>
<name>1</name>
<name>Cbfa1a</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q13950-2</id>
<name>2</name>
<sequence type="described" ref="VSP_005937"/>
</isoform>
<isoform>
<id>Q13950-3</id>
<name>3</name>
<name>Cbfa1b</name>
<sequence type="described" ref="VSP_005938"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Specifically expressed in osteoblasts.</text>
</comment>
<comment type="domain">
<text>A proline/serine/threonine rich region at the C-terminus is necessary for transcriptional activation of target genes and contains the phosphorylation sites.</text>
</comment>
<comment type="PTM">
<text evidence="3 18">Phosphorylated; probably by MAP kinases (MAPK). Phosphorylation by HIPK3 is required for the SPEN/MINT and FGF2 transactivation during osteoblastic differentiation (By similarity). Phosphorylation at Ser-451 by CDK1 promotes endothelial cell proliferation required for tumor angiogenesis probably by facilitating cell cycle progression. Isoform 3 is phosphorylated on Ser-340.</text>
</comment>
<comment type="disease" evidence="7 8 9 10 11 13 15 16 17 20 21 22 24 25 26 27 28 29">
<disease id="DI-01353">
<name>Cleidocranial dysplasia</name>
<acronym>CLCD</acronym>
<description>Autosomal dominant skeletal disorder with high penetrance and variable expressivity. It is due to defective endochondral and intramembranous bone formation. Typical features include hypoplasia/aplasia of clavicles, patent fontanelles, wormian bones (additional cranial plates caused by abnormal ossification of the calvaria), supernumerary teeth, short stature, and other skeletal changes. In some cases defects in RUNX2 are exclusively associated with dental anomalies.</description>
<dbReference type="MIM" id="119600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="23">
<disease id="DI-03699">
<name>Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly</name>
<acronym>MDMHB</acronym>
<description>An autosomal dominant bone dysplasia characterized by metaphyseal flaring of long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, variable brachydactyly, and dystrophic teeth.</description>
<dbReference type="MIM" id="156510"/>
</disease>
<text evidence="23">The disease is caused by mutations affecting the gene represented in this entry. Analysis for copy-number variations revealed that a 105 kb duplication within RUNX2 segregated with the MDMHB phenotype in a region with maximum linkage. Real-time PCR for copy-number variation in genomic DNA in eight samples, as well as sequence analysis of fibroblast cDNA from one subject with MDMHB confirmed that affected family members were heterozygous for the presence of an intragenic duplication encompassing exons 3 to 5 of RUNX2. These three exons code for the Q/A domain and the functionally essential DNA-binding Runt domain of RUNX2. The RUNX2 duplication found in individuals with MDMHB leads to a gain of function (PubMed:23290074).</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/RUNX2ID42183ch6p21.html"/>
</comment>
<dbReference type="EMBL" id="AF001450">
<property type="protein sequence ID" value="AAB65159.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001443">
<property type="protein sequence ID" value="AAB65159.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001444">
<property type="protein sequence ID" value="AAB65159.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001445">
<property type="protein sequence ID" value="AAB65159.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001446">
<property type="protein sequence ID" value="AAB65159.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001447">
<property type="protein sequence ID" value="AAB65159.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001448">
<property type="protein sequence ID" value="AAB65159.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001449">
<property type="protein sequence ID" value="AAB65159.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001450">
<property type="protein sequence ID" value="AAB65158.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001444">
<property type="protein sequence ID" value="AAB65158.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001445">
<property type="protein sequence ID" value="AAB65158.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001446">
<property type="protein sequence ID" value="AAB65158.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001447">
<property type="protein sequence ID" value="AAB65158.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001448">
<property type="protein sequence ID" value="AAB65158.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001449">
<property type="protein sequence ID" value="AAB65158.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL161907">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL358135">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL096865">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF053952">
<property type="protein sequence ID" value="AAC78624.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF053949">
<property type="protein sequence ID" value="AAC77441.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L40992">
<property type="protein sequence ID" value="AAA89072.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43467.2">
<molecule id="Q13950-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43468.2">
<molecule id="Q13950-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001015051.3">
<molecule id="Q13950-3"/>
<property type="nucleotide sequence ID" value="NM_001015051.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001019801.3">
<molecule id="Q13950-1"/>
<property type="nucleotide sequence ID" value="NM_001024630.3"/>
</dbReference>
<dbReference type="BMRB" id="Q13950"/>
<dbReference type="SMR" id="Q13950"/>
<dbReference type="BioGRID" id="107308">
<property type="interactions" value="50"/>
</dbReference>
<dbReference type="CORUM" id="Q13950"/>
<dbReference type="DIP" id="DIP-36707N"/>
<dbReference type="ELM" id="Q13950"/>
<dbReference type="IntAct" id="Q13950">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="MINT" id="Q13950"/>
<dbReference type="STRING" id="9606.ENSP00000360493"/>
<dbReference type="iPTMnet" id="Q13950"/>
<dbReference type="PhosphoSitePlus" id="Q13950"/>
<dbReference type="SwissPalm" id="Q13950"/>
<dbReference type="BioMuta" id="RUNX2"/>
<dbReference type="DMDM" id="17368460"/>
<dbReference type="EPD" id="Q13950"/>
<dbReference type="jPOST" id="Q13950"/>
<dbReference type="MassIVE" id="Q13950"/>
<dbReference type="MaxQB" id="Q13950"/>
<dbReference type="PaxDb" id="Q13950"/>
<dbReference type="PeptideAtlas" id="Q13950"/>
<dbReference type="PRIDE" id="Q13950"/>
<dbReference type="ProteomicsDB" id="59767">
<molecule id="Q13950-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="59768">
<molecule id="Q13950-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="59769">
<molecule id="Q13950-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="3645">
<property type="antibodies" value="867 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="860"/>
<dbReference type="Ensembl" id="ENST00000359524">
<molecule id="Q13950-2"/>
<property type="protein sequence ID" value="ENSP00000352514"/>
<property type="gene ID" value="ENSG00000124813"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000371432">
<molecule id="Q13950-3"/>
<property type="protein sequence ID" value="ENSP00000360486"/>
<property type="gene ID" value="ENSG00000124813"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000371436">
<molecule id="Q13950-3"/>
<property type="protein sequence ID" value="ENSP00000360491"/>
<property type="gene ID" value="ENSG00000124813"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000371438">
<molecule id="Q13950-1"/>
<property type="protein sequence ID" value="ENSP00000360493"/>
<property type="gene ID" value="ENSG00000124813"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000647337">
<molecule id="Q13950-1"/>
<property type="protein sequence ID" value="ENSP00000495497"/>
<property type="gene ID" value="ENSG00000124813"/>
</dbReference>
<dbReference type="GeneID" id="860"/>
<dbReference type="KEGG" id="hsa:860"/>
<dbReference type="UCSC" id="uc003oxt.5">
<molecule id="Q13950-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="860"/>
<dbReference type="DisGeNET" id="860"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000124813.20"/>
<dbReference type="GeneCards" id="RUNX2"/>
<dbReference type="GeneReviews" id="RUNX2"/>
<dbReference type="HGNC" id="HGNC:10472">
<property type="gene designation" value="RUNX2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000124813">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="RUNX2"/>
<dbReference type="MIM" id="119600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="156510">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600211">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13950"/>
<dbReference type="OpenTargets" id="ENSG00000124813"/>
<dbReference type="Orphanet" id="1452">
<property type="disease" value="Cleidocranial dysplasia"/>
</dbReference>
<dbReference type="Orphanet" id="2504">
<property type="disease" value="Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA34885"/>
<dbReference type="eggNOG" id="KOG3982">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160171"/>
<dbReference type="InParanoid" id="Q13950"/>
<dbReference type="KO" id="K09278"/>
<dbReference type="OMA" id="XVVALGE"/>
<dbReference type="OrthoDB" id="562214at2759"/>
<dbReference type="PhylomeDB" id="Q13950"/>
<dbReference type="TreeFam" id="TF321496"/>
<dbReference type="PathwayCommons" id="Q13950"/>
<dbReference type="Reactome" id="R-HSA-2032785">
<property type="pathway name" value="YAP1- and WWTR1 (TAZ)-stimulated gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8878166">
<property type="pathway name" value="Transcriptional regulation by RUNX2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939246">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of myeloid cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939902">
<property type="pathway name" value="Regulation of RUNX2 expression and activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8940973">
<property type="pathway name" value="RUNX2 regulates osteoblast differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941284">
<property type="pathway name" value="RUNX2 regulates chondrocyte maturation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941326">
<property type="pathway name" value="RUNX2 regulates bone development"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941332">
<property type="pathway name" value="RUNX2 regulates genes involved in cell migration"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941333">
<property type="pathway name" value="RUNX2 regulates genes involved in differentiation of myeloid cells"/>
</dbReference>
<dbReference type="SignaLink" id="Q13950"/>
<dbReference type="SIGNOR" id="Q13950"/>
<dbReference type="BioGRID-ORCS" id="860">
<property type="hits" value="42 hits in 895 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RUNX2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="RUNX2"/>
<dbReference type="GenomeRNAi" id="860"/>
<dbReference type="Pharos" id="Q13950">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q13950"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="RNAct" id="Q13950">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000124813">
<property type="expression patterns" value="Expressed in tibia and 181 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q13950">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13950">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0043425">
<property type="term" value="F:bHLH transcription factor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070491">
<property type="term" value="F:repressing transcription factor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030509">
<property type="term" value="P:BMP signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048469">
<property type="term" value="P:cell maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071773">
<property type="term" value="P:cellular response to BMP stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002063">
<property type="term" value="P:chondrocyte development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002062">
<property type="term" value="P:chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048701">
<property type="term" value="P:embryonic cranial skeleton morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035115">
<property type="term" value="P:embryonic forelimb morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001958">
<property type="term" value="P:endochondral ossification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045879">
<property type="term" value="P:negative regulation of smoothened signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042475">
<property type="term" value="P:odontogenesis of dentin-containing tooth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001503">
<property type="term" value="P:ossification"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002076">
<property type="term" value="P:osteoblast development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001649">
<property type="term" value="P:osteoblast differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002051">
<property type="term" value="P:osteoblast fate commitment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032332">
<property type="term" value="P:positive regulation of chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045669">
<property type="term" value="P:positive regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901522">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045595">
<property type="term" value="P:regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0040036">
<property type="term" value="P:regulation of fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042487">
<property type="term" value="P:regulation of odontogenesis of dentin-containing tooth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048863">
<property type="term" value="P:stem cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030217">
<property type="term" value="P:T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.720">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.770.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000040">
<property type="entry name" value="AML1_Runt"/>
</dbReference>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR012346">
<property type="entry name" value="p53/RUNT-type_TF_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013524">
<property type="entry name" value="Runt_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027384">
<property type="entry name" value="Runx_central_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013711">
<property type="entry name" value="RunxI_C_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016554">
<property type="entry name" value="TF_Runt-rel_RUNX"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11950">
<property type="entry name" value="PTHR11950"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00853">
<property type="entry name" value="Runt"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08504">
<property type="entry name" value="RunxI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF009374">
<property type="entry name" value="TF_Runt-rel_RUNX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00967">
<property type="entry name" value="ONCOGENEAML1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51062">
<property type="entry name" value="RUNT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Runt-related transcription factor 2" id="PRO_0000174659">
<location>
<begin position="1"/>
<end position="521"/>
</location>
</feature>
<feature type="domain" description="Runt" evidence="6">
<location>
<begin position="101"/>
<end position="229"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with FOXO1" evidence="3">
<location>
<begin position="242"/>
<end position="258"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with KAT6A" evidence="3">
<location>
<begin position="336"/>
<end position="439"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with KAT6B" evidence="12">
<location>
<begin position="374"/>
<end position="468"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="49"/>
<end position="71"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="73"/>
<end position="89"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro/Ser/Thr-rich">
<location>
<begin position="237"/>
<end position="521"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="4">
<location>
<position position="267"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1" evidence="18">
<location>
<position position="451"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="2">
<location>
<position position="238"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_005937" evidence="31">
<original>MASNSLFSTVTPCQQNFFW</original>
<variation>MRIPV</variation>
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_005938" evidence="30">
<location>
<begin position="341"/>
<end position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064081" evidence="13">
<original>Q</original>
<variation>L</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; decreased subcellular localization in the nucleus; decreased transactivation activity." id="VAR_079576" evidence="27">
<location>
<begin position="67"/>
<end position="521"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_012131" evidence="28">
<location>
<begin position="78"/>
<end position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; the patient also shows brachydactyly of hands and feet." id="VAR_012130" evidence="28">
<original>A</original>
<variation>AAAAAAAAAAA</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; unchanged subcellular localization; decreased transactivation activity." id="VAR_012132" evidence="7 27">
<original>L</original>
<variation>R</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064082" evidence="22">
<original>S</original>
<variation>N</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_012133" evidence="7">
<original>S</original>
<variation>R</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_012134" evidence="7">
<original>F</original>
<variation>C</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_012135" evidence="7">
<original>C</original>
<variation>R</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064083" evidence="22 24">
<original>R</original>
<variation>C</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064084" evidence="17">
<original>R</original>
<variation>G</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064085" evidence="22">
<original>R</original>
<variation>S</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_012136" evidence="8">
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064086" evidence="22">
<original>L</original>
<variation>P</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064087" evidence="22">
<original>V</original>
<variation>D</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064088" evidence="11">
<original>V</original>
<variation>G</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; dbSNP:rs104893995." id="VAR_064089" evidence="11 16">
<original>R</original>
<variation>P</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; dbSNP:rs104893995." id="VAR_012137" evidence="8">
<original>R</original>
<variation>Q</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064090" evidence="22">
<original>M</original>
<variation>K</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; abolishes DNA binding; dbSNP:rs104893989." id="VAR_012138" evidence="8 26 29">
<original>M</original>
<variation>R</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; dbSNP:rs201647225." id="VAR_064091" evidence="22">
<original>M</original>
<variation>V</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; unchanged subcellular localization; decreased transactivation activity." id="VAR_079577" evidence="27">
<original>R</original>
<variation>T</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064092" evidence="22">
<original>F</original>
<variation>S</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; abolishes DNA binding; dbSNP:rs1057521068." id="VAR_012139" evidence="8 26">
<original>R</original>
<variation>Q</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; has severely impaired DNA binding and transactivation." id="VAR_012140" evidence="10 11 15">
<original>R</original>
<variation>W</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; abolishes DNA binding; dbSNP:rs104893990." id="VAR_012141" evidence="8 29">
<original>S</original>
<variation>N</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_012142" evidence="8">
<original>R</original>
<variation>C</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; unchanged subcellular localization; decreased transactivation activity." id="VAR_079578" evidence="25">
<original>R</original>
<variation>G</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064093" evidence="22">
<original>R</original>
<variation>Q</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; retains heterodimerization activity together with a trace potential for DNA binding; retains a low but still substantial transactivation activity." id="VAR_012143" evidence="9 15">
<original>F</original>
<variation>S</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; abolishes DNA binding." id="VAR_012144" evidence="8">
<original>L</original>
<variation>F</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; mild; associated also with isolated dental anomalies; normal DNA binding; dbSNP:rs104893993." id="VAR_012145" evidence="8">
<original>T</original>
<variation>A</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064094" evidence="22">
<original>T</original>
<variation>I</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064095" evidence="11">
<original>I</original>
<variation>K</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_012146" evidence="7">
<original>T</original>
<variation>R</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064096" evidence="22">
<original>Q</original>
<variation>H</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_012147" evidence="8">
<original>Q</original>
<variation>R</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064097" evidence="22">
<original>A</original>
<variation>P</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064098" evidence="22">
<original>K</original>
<variation>E</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; has severely impaired DNA binding and transactivation; dbSNP:rs752933596." id="VAR_064099" evidence="15">
<original>K</original>
<variation>N</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064100" evidence="22">
<original>K</original>
<variation>Q</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; has severely impaired DNA binding and transactivation." id="VAR_064101" evidence="15">
<original>T</original>
<variation>I</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064102" evidence="22">
<original>R</original>
<variation>L</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; interferes with nuclear localization; abolishes DNA binding; dbSNP:rs104893991." id="VAR_012148" evidence="7 8 11 15 17 26">
<original>R</original>
<variation>Q</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; interferes with nuclear localization; has severely impaired DNA binding and transactivation; dbSNP:rs104893992." id="VAR_012149" evidence="7 11 15 20 27">
<original>R</original>
<variation>W</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064103" evidence="22">
<original>R</original>
<variation>G</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064104" evidence="22">
<original>K</original>
<variation>R</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064105" evidence="22">
<original>D</original>
<variation>N</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064106" evidence="11">
<original>A</original>
<variation>V</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; unchanged subcellular localization; decreased transactivation activity." id="VAR_079579" evidence="25">
<location>
<begin position="400"/>
<end position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064107" evidence="21">
<original>T</original>
<variation>I</variation>
<location>
<position position="420"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD." id="VAR_064108" evidence="22">
<original>T</original>
<variation>N</variation>
<location>
<position position="420"/>
</location>
</feature>
<feature type="sequence variant" description="In CLCD; decreased protein stability; decreased transactivation activity; decreased osteoblast differentiation." id="VAR_079580" evidence="26">
<location>
<begin position="462"/>
<end position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11498198." id="VAR_012150" evidence="7">
<original>G</original>
<variation>S</variation>
<location>
<position position="511"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced DNA-binding and impaired phosphorylation." evidence="18">
<original>S</original>
<variation>A</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAC77441." ref="4" evidence="31">
<original>N</original>
<variation>S</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location sequence="Q13950-3">
<position position="340"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q08775"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Z2J9"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00399"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10521292"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10545612"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10689183"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10980549"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11857736"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11965546"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12081718"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12145306"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12196916"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12424590"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16270353"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16407259"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17377532"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19744171"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20082269"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20648631"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23290074"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24984680"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28505335"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28703881"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28738062"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9182765"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9207800"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9233771"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305"/>
<sequence length="521" mass="56648" checksum="44C4F3867D6F3EB1" modified="2001-11-02" version="2">MASNSLFSTVTPCQQNFFWDPSTSRRFSPPSSSLQPGKMSDVSPVVAAQQQQQQQQQQQQQQQQQQQQQQQEAAAAAAAAAAAAAAAAAVPRLRPPHDNRTMVEIIADHPAELVRTDSPNFLCSVLPSHWRCNKTLPVAFKVVALGEVPDGTVVTVMAGNDENYSAELRNASAVMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKVTVDGPREPRRHRQKLDDSKPSLFSDRLSDLGRIPHPSMRVGVPPQNPRPSLNSAPSPFNPQGQSQITDPRQAQSSPPWSYDQSYPSYLSQMTSPSIHSTTPLSSTRGTGLPAITDVPRRISDDDTATSDFCLWPSTLSKKSQAGASELGPFSDPRQFPSISSLTESRFSNPRMHYPATFTYTPPVTSGMSLGMSATTHYHTYLPPPYPGSSQSQSGPFQTSSTPYLYYGTSSGSYQFPMVPGGDRSPSRMLPPCTTTSNGSTLLNPNLPNQNDGVDADGSHSSSPTVLNSSGRMDESVWRPY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

